articleTop 1% cited

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Journal of Pharmacology and Experimental Therapeutics · 2002 · Vol. 302(1) · pp. 381–389

Kevin D. Burris✉(Bristol-Myers Squibb (United States))Thaddeus F. MolskiCen XuElaine RyanKatsura TottoriTetsuro KikuchiFrank D. YoccaPerry B. Molinoff

View via DOI Publisher page

Receptor Mechanisms and Signaling Neurotransmitter Receptor Influence on Behavior Neuropeptides and Animal PhysiologyAripiprazolePartial agonistDopamine receptor D2AgonistChemistryPharmacologyDopamineEndogenous agonistReceptorDopamine receptor

MeSH terms

AripiprazoleCyclic AMPAnimalsColforsinCricetinaeHumansPiperazinesRadioligand AssaySpiperoneAntipsychotic Agents1-Methyl-3-isobutylxanthineQuinolonesSignal TransductionCHO CellsReceptors, Dopamine D2

Citations

915

FWCI

12.78

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Comparative efficacy of clozapine and aripiprazole in reducing negative symptoms in schizophrenia

International Journal of Research in Psychiatry · 2025 · 0 citations

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Journal of Pharmacology and Experimental Therapeutics · 2006 · 1,103 citations

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

Schizophrenia Research · 2003 · 469 citations

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

Molecular Psychiatry · 2004 · 974 citations

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Psychopharmacology · 2003 · 531 citations

Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology

Neuropharmacology · 2019 · 372 citations

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

Neuropsychopharmacology · 2003 · 967 citations

How were new medicines discovered?

Nature Reviews Drug Discovery · 2011 · 1,768 citations

References

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

Annals of the New York Academy of Sciences · 1949 · 19,863 citations

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Biochemical Pharmacology · 1973 · 12,855 citations

A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

Analytical Biochemistry · 1976 · 225,297 citations

Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus

Molecular Pharmacology · 1998 · 512 citations

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Analytical Biochemistry · 1976 · 209,807 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.